The Global Hormone Refractory Breast Cancer Market is expected to growing at a CAGR of 4% during the forecast period 2022-2028. Hormone refractory breast cancer, also known as hormone resistance, is defined as a condition in which breast cancer does not respond or is ineffective to hormone therapy. Most advanced breast cancers become hormone refractory […]
